Molecular Health

Last chance to join our webinar to learn how to overcome IVDR challenges. Register now: eu1.hubs.ly/H01YzX30 #webinar #laboratory #ivdr #precisionmedicine #ngs #cancer

Meeting requirements of the IVDR will go hand-in-hand with the implementation of new ideas. What are those requirements? How can you anticipate white space for new developments? Register today: eu1.hubs.ly/H01YCH40 #webinar #laboratory #ivdr #precisionmedicine #ngs #cancer

With new requirements coming into effect under IVDR, future-proofing your LDTs is likely on your mind. Let us help you assess the tests, workflows, and operations of your lab in light of IVDR. Register today: eu1.hubs.ly/H01YCGZ0 #webinar #laboratory #ivdr

Last chance to join our webinar to learn what everyone should know about comprehensive genomic profiling. Register for free: eu1.hubs.ly/H01Mx_80 #webinar #precisionmedicine #cancer #diagnostics #comprehensivegenomicprofiling #oncology #nsclc #treatment #genomics

EGFR, ALK, ROS1 and PD-L1 testing are nearly universally recommended by national guidelines in management of NSCLC patients. And yet, patients still go untested (doi: 10.1016/j.lungcan.2020.10.012). Genomic profiling can help close that gap: eu1.hubs.ly/H01MzCW0

The answer to optimal treatment decisions lies in your patients’ genes. Join our #webinar to learn what everyone should know about comprehensive genomic profiling: eu1.hubs.ly/H01Mx_10 #webinar #precisionmedicine #cancer #diagnostics #oncology #nsclc #treatment #genomics #ngs

CGP combined with classification of detected genomic alterations according to ESCAT is a powerful tool to advance treatment decisions for cancer patients (eu1.hubs.ly/H01MzCB0). Join our educational webinar to learn more on CGP: eu1.hubs.ly/H01MzCC0

Molecular Health freut sich, das 16. Rhein-Main Symposium als Sponsor und Aussteller zu unterstützen. Erhalten Sie einen Überblick über wichtige Studienergebnisse des ESMO 2022. Melden Sie sich jetzt noch kostenfrei an: eu1.hubs.ly/H01D_5H0

SAVE THE DATE: 16. Rhein-Main Symposium Molecular Health freut sich, die Veranstaltung am 17. September als Sponsor und Aussteller zu unterstützen. Zum Programm: eu1.hubs.ly/H01D_4x0 #mammakarzinom #krebs #ngs #precisionmedicine #mhguide #molekular #tumor #diagnostik

More than any other form, non-small cell lung cancer has transitioned to molecularly stratified therapies. Which biomarkers are recommended by guidelines and how often are they really tested? Find out in our white paper: eu1.hubs.ly/H01z1NM0 #precisionmedicine #mhguide

Are you attending the #ECP2022Basel? Join us tomorrow at 7:15 am CEST for our breakfast symposium “From Genes to Decisions.” to learn how pathologists can master the surging data flood of comprehensive genomic profiling. #ECP2022Basel #precisionmedicine #molecularpathology

The Art of Next-Generation Pathology – this year's European Congress of Pathology covers many topics relevant for modern pathologies. Molecular Health will be there in person. Visit us at booth 12 in Hall 4.1. #ECP2022Basel #molecularpathology #cancer #dataanalytics

Comprehensive molecular diagnostics will increase in relevance for prostate carcinoma. Here’s a quick summary of what can be learned. Read our white paper: eu1.hubs.ly/H01z1Nw0 #precisionmedicine #molecularpathology #cancer #mhguide #genomics

Read about relevant molecular alterations in #cholangiocarcinoma and current thinking about tumor profiling. Download our white paper: eu1.hubs.ly/H01yL900 #precisionmedicine #molecularpathology #cancer#diagnostics #dataanalytics #sequencing#treatment #oncology #pathology

MH Guide from Molecular Health is a clinical decision support software that assists molecular diagnostics by interpreting complex next generation sequencing (NGS) datasets and translating the information into clinically relevant knowledge. Learn more: eu1.hubs.ly/H01yHhQ0

Save the date for the 34th European Congress of Pathology in Basel and meet us from 3-7 September 2022 at booth 12 to learn more about our fast clinical decision support. eu1.hubs.ly/H01rFKC0 #ECP2022Basel #mhguide #molecularhealth

Today is #WorldLungCancerDay, a call for awareness about the disease and its treatment. Did you know that first-line therapies require testing for 6 different biomarkers? Which are they and why do organizations recommend analyzing all of them at once? eu1.hubs.ly/H01q1wQ0

MH Guide assigns a CVI score that classifies a biomarker. It also displays the biomarker’s AMP/ASCO/CAP evidence category (tier I–IV). This way, you can quickly assess the clinical relevance of each detected biomarker to make informed treatment decisions. eu1.hubs.ly/H01frhy0

MH Guide is platform, assay and panel-agnostic. It is used by partnering laboratories to evaluate multi-gene #panels, like the TSO500. MH Guide integrates results from various #molecular profiling methodologies. eu1.hubs.ly/H01fqXK0 #precisionmedicine #pathology #mhguide

Molecular Health receives #IVDR certification for MH Guide! Molecular #pathology laboratories now benefit from the highest possible diagnostic reliability and quality in the automated interpretation of #genetic tumor profiles. eu1.hubs.ly/H01jvmj0 #mhguide #annotation